Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
China
· Delayed Price · Currency is CNY 30.02
+0.17 (0.57%)
May 23, 2025, 2:45 PM CST
SHE:300049 Revenue
In the year 2024, Inner Mongolia Furui Medical Science had annual revenue of 1.35B CNY with 16.93% growth. Inner Mongolia Furui Medical Science had revenue of 330.40M in the quarter ending March 31, 2025, with 2.35% growth.
Revenue
1.35B
Revenue Growth
+16.93%
P/S Ratio
5.91
Revenue / Employee
1.92M
Employees
703
Market Cap
7.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.35B | 195.28M | 16.93% |
| Dec 31, 2023 | 1.15B | 144.97M | 14.37% |
| Jan 1, 2023 | 1.01B | 110.28M | 12.27% |
| Jan 1, 2022 | 898.48M | 90.95M | 11.26% |
| Dec 31, 2020 | 807.53M | -24.21M | -2.91% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |